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Agriculture in developing countries faces a huge challenge. In the next 50 years the number of 
people living in the world's poorer countries will increase from 5 billion to 8 billion. To feed these 
people farmers in 2050 will need to produce at least 50% more food, which for the 2000-2001 
World Resources Report, could have devastating implications for human development and the 
welfare of all species.  
Paul Ehrlich, one of the most influential ecologists in the USA and author of the book The 
Population Bomb, developed an equation in the 1970s to describe the impact of human 
population on the environment. A version of this equation, called the population-resource 
equation, helps put the challenge facing agriculture into stark perspective. The equation says 
that: 
(Natural resource use) x (technology) = (population) x (per capita consumption).i
Given that populations are growing, per capita consumption needs to increase to feed the 830 
million underfed people in the world, and our natural resource base is already seriously damaged, 
the only option would appear to be very rapid technological change. Is this really the only option? 
And if so, where are these technology gains going to come from?  
Vernon Ruttan, a professor emeritus in the Departments of Economics and Applied Economics at 
the University of Minnesota believes, as do many others, that biotechnology is the answer. Ruttan 
writes, "biotechnology is poised to become the most important new general-purpose technology 
in the first half of the twenty-first century"ii. The private sector agrees. Monsanto puts it this way: 
"agricultural biotechnology will play a major role in realising the hope we all share. Accepting this, 
science can make a dramatic difference to millions of lives." 
There is a strong opposing view. The United Nations (UN) Development Programme's Human 
Development Report 2001, published in July, urges that there should be "greater public 
investment in GM [genetically modified] research and development to ensure it meets the needs 
of the poor". However, the report was immediately slated by nearly 300 organisations around the 
world, including Oxfam, Greenpeace International and Action Aid who chastised the UN for its 
uncritical support for biotechnology. The fact that so many organisations were so quick in their 
condemnation bears testament to how deeply and widely reservations about biotechnology are 
held. Indeed, this feeling has already led to a consumer boycott against GM food in Europe that 
has included GM food being barred from the menu at the UK headquarters of a transnational 
biotech company. 
In our opinion the debate has become polarised and the result is 'two-value thinking'-the 
assumption, frequently unexamined, that every question has two sides, and only two sides, and 
that organisations and individuals are either on one side or the other. In this article we examine 
the issues on both sides of the debate and suggest a way through the middle that, while not 
seeing biotechnology as the new panacea, does not dismiss it as a false and dangerous dawn. 
Technology change that biotechnology may or may not bring is at the heart of both people's 
hopes and people's fears. Some have found it useful to think of technology change as an 
evolutionary process. People, as a result of the pressures they face and the opportunities they 
see, learn and then generate new ideas, things, and ways of organising themselves. If these 
novelties work well then others adopt them and they spread. Agricultural change is built up of 
many replications of this novelty generation, selection and diffusion process, just as we have 
evolved through countless natural selection iterations. Unlike natural selection though, this 
'learning selection' process is not blind. Who benefits depends on who generates the novelties, 
how selection decisions are made, and how innovations are promulgated. 
The main role of science in agriculture has been to propel this evolutionary process by generating 
novelties that allow us to produce more with less land and less effort. Results have been 
spectacular. The Consultative Group on International Agricultural Research (CGIAR), a grouping 
of 16 international agricultural research institutes, is best known for starting the Green Revolution 
of rice and wheat in Asia. In the 30 years from 1971 to 2000 the improved crop varieties produced 
by the International Rice Research Institute (IRRI) and the Centro Internacional de Mejoramiento 
de Maíz y Trigo (CIMMYT) have helped raise average rice and wheat yields by 2.3 and 1.65 
times respectively, helping to feed an Asian population that grew by almost 70% in the same 
period. Data from the UN Food and Agriculture Organization (FAO) show that from 1961 to 1991 
the Asian population doubled from 1.6 to 3.4 billion (Article published by IRRI). In the same 
period, rice production grew from 199 million tonnes in 1961 to 540 million tonnes in 2000 
(170%), thanks largely to the yield associated to the new, improved rice varieties. Using these 
data, a team of researchers from IRRI found that the total annual gains from the adoption of these 
new modern rice varieties now stand at US $ 10.8 billion, i.e., about 150 times the total 
investment made in rice research over the same 40-year period by IRRI and its national research-
for-development partners in Asia. 
The Green Revolution crop varieties were novelties that farmers rushed to adopt. In 1982, IR36 
was planted on 11 million hectares, making it the most widely planted rice cultivar ever. However, 
problems emerged when millions of rice farmers all moved from growing a number of their 
traditional landraces to just one or two genetically homogenous cultivars. Some of the resistance 
that the breeders had given the improved varieties against pests and diseases broke down within 
3 to 5 years leading to huge crop losses. In Indonesia, for example, a fifth of farmers lost their 
entire crop to brown plant hoppers in 1985 and 1986. Farmers in Thailand and the Philippines 
suffered a similar fate.  
In evolutionary terms the cause of the problem was not with the novelties per se, but with the 
selection and diffusion mechanisms that led to the technologies being so widely adopted without 
considering the consequences. Farmers did not know the consequences because they were used 
to operating on the scale of their own fields, not to thinking about what might happen over millions 
of hectares. And the research and extension systems that were encouraging them to adopt did 
not know the consequences either. This has been a salutary lesson to the CGIAR system: 
reductionist science that isolates problems and ignores contexts and scale issues can become 
horribly unstuck even in relatively simple agroecosystems. It does not necessarily produce 
sustainable solutions.  
The world now needs a second Green Revolution to feed growing populations in developing 
countries. We believe that biotechnology has a role to play, but only if the lessons of the first 
Green Revolution, and from decades of experience in agricultural development in general, are 
learnt. In addition to the lesson about reductionist science, these lessons are: 
• farming in developing countries is profoundly different to farming in developed countries;  
• farms are generally small, and farming systems often complex and 'fine grained' where 
each grain represents a different set of opportunities and constraints that often require 
different solutions; 
• technologies, in general, do not transfer from developed to developing countries. Rather, 
they need to be built up in situ using local knowledge and innovative ability after which, if 
successful, they will spread from farmer to farmer; 
• sustainability is about empowering local communities to be able to adapt successfully to 
change; and 
• if a country produces enough food to feed itself this does not mean there is no hunger. 
Whether people have enough food is determined by infrastructure and government 
policy, as well as who has access to technology. 
To help farming in developing countries, therefore, biotechnology needs to support local 
innovative capacity and to be assessable. Local people and institutions need to be in control of 
the novelty generation, selection and diffusion processes. Biotechnology will not help the poor if it 
is transferred in a top-down, reductionist way, from first world to third. However, there is real 
concern that this is what is going to happen because of some actions taken by large multinational 
biotech companies. An example is the use of so-called Genetic Use Restriction Technologies 
(GURTs) to develop 'Terminator seeds', i.e., seeds modified to produce infertile seed thus forcing 
farmers to buy new seed every year. This makes good sense for a company whose primary 
loyalty is to making profits for its shareholders, but is not at all in the interest of the 1.4 billion 
people, nearly all living in developing countries who rely on saved seed as their primary seed 
source. Furthermore, such technology threatens to undermine the indigenous innovation system 
that over the last 10,000 years has 'invented' and then refined the world's crops. 
A related threat to indigenous innovation is the current patent system that offers no protection for 
indigenous and community-based innovation to private sector claims. The US patent on the 
Mexican enola bean, for example, raises the spectre of poor farmers being prevented from 
growing seed they have been breeding for centuries.  
Hopefully biotechnology will never be used to thwart indigenous plant breeding in developing 
countries. Some in the private seed sector (i.e. Monsanto and Syngenta) have already given 
commitments not to use GURTs. Both companies see it in their own interest to develop 
partnerships with the public sector that will help bring benefits to developing countries. In April 
2000, for example, Monsanto announced that it was making its draft rice genome sequence data 
available to public researchers involved in the International Rice Genome Sequencing Project. 
Within this decade, research in crop improvement will also be targeting improvement of food 
quality, i.e. vitamin A content. Golden Rice and other crops with capacity to produce beta-
carotene may contribute to a balanced diet in poor rural areas as well as new demands for varied 
diet from urban populations with enhanced income. The private sector announced that some of 
the patents associated with the development of GoldenRice will not be enforced to allow 
consumers in the developing world to benefit from this new crop variety. Research groups are 
already attempting to improve GoldenRice further by enhancing the quality of the rice protein to 
contain more essential amino acids. 
The UN Human Development Report believes, however, that relying on the spotlight of public 
opinion to encourage multinationals to do the right thing is not sufficient. A main conclusion from 
the report is that policy, not charity, will determine whether new technologies become a tool for 
human development everywhere. One solution the authors suggest is that rich countries support 
a global effort to create incentives and new partnerships for research and development. The 
biotech products developed by the private sector must be deployed in a way that considers both 
environmental and human health issues. While this discussion remains sensitive, particularly for 
the inhabitants of the industrialised world, it is a debate in which the developing world should 
have a voice, and must set its own biosafety standards within the context of economy, ecology 
and climate. Of course, scientists and policy makers in the developing world must ensure that the 
New Science serves the needs and aspirations of their people. Some of these biosafety issues 
need to be addressed while deploying transgenic technology: 
• transgenic plants should not lead to new pests or new pest strains;  
• transgenic technology for pest control should not affect non-target organisms;  
• transgenic food should not pose a health risk;  
• agrobiodiversity should not be suppressed by adoption of new transgenic crops; and  
• transgenic plants should not affect agroecosystems if new lands are to be incorporated 
into agriculture.  
An interesting example of research-for-development in biotechnology is provided by 
CAMBIA,Center for the Application of Molecular Biology, to International Agriculture. This is a not-
for-profit research institute in Canberra, Australia, which was set up in 1991 to develop and 
package the novelty generation and selection tools that biotechnology is making possible so that 
farmers and local researchers can use them. One of the technologies is 'transactivation', which is 
based on the fact that much of the genetic variability in plants comes not from the presence or 
absence of genes, but from gene regulation, i.e., the extent to which genes are 'turned on' and in 
which tissues. Manipulating gene activity in this way can create a composite crop population with 
a tremendous degree of variety. The plan is to provide breeders and farmers with populations of 
these 'turned on' plants to allow them to select the novelties they want. The power of this 
approach is that it allows farmers and breeders to scan the evolutionary history of a crop and 
recreate a vast range of novelty that might have existed at some point but died out almost 
immediately through natural selection. Such novelty might be of huge benefit because what a 
farmer requires from a crop can be the opposite to what a plant needs to survive in nature. 
Functional genomics and transactivation are just some technologies that fall under the heading of 
'biotechnology' which can provide both opportunities and risks to developing countries, depending 
on how they are used. Others include: 
• Tissue culture-together with improved selection techniques tissue culture allows plant 
breeders to generate a new plant variety in a few generations rather than the many 
required using conventional techniques. 
• DNA probes that allow genes conveying desired traits to be identified much more reliably 
and faster than conventional 'phenotyping', i.e., identifying the desired gene from the 
traits it produces in plants growing in the field or greenhouse. DNA probes also make it 
possible to screen for several genes simultaneously which is very important because 
features such as high yields and stable resistance to pests and diseases come from the 
interaction of a number of genes, rather than the presence of just one.  
• Genetic engineering, i.e., the manipulation of an organism's genetic information by 
introducing or eliminating a specific gene. Whereas in conventional plant breeding, 
breeders are tied to using genes from the same species, genetic engineering allows them 
to look almost anywhere for genes providing the traits they desire.  
Genetic engineering is the technology that provides the greatest perceived threat and has caused 
the most controversy. One area of concern is whether GM plants and food are safe for humans 
and animals to eat. So far the most potent 'smoking gun' has been the finding that pollen from 
GM maize kills Monarch butterflies in lab experiments (but not yet confirmed by field research). 
There are also concerns that proteins in GM food might also cause allergic reactions.  
A more important area of concern for developing countries is whether GM organisms will 'flow' to 
other organisms. For example, a rice plant genetically modified to have drought tolerance would 
sooner or later out-cross with weedy rice. This could produce 'super-weedy' rice that might 
exasperate the already serious problem that South American farmers have with weedy rice. The 
more general fear is that plants or animals that gain genes that confer some advantage would 
then outcompete and reduce biodiversity. This is a greater threat for developing countries, which 
contain the centres of biodiversity for the world's most important crops, than for developed 
countries. However, there are no records of a plant becoming a weed as a result of plant 
breeding. Interspecific hybridisation appears to be rare in nature, and resulting hybrids are mostly 
sterile.  
Conclusions 
Whether biotech helps balance Ehrlich's equation depends on how it is used, and by whom. 
Nearly everything points to policy. Clear, strong and equitable policy is needed in both developed 
(innovative incentive and funding structures) and developing countries (biosafety regulations, 
intellectual property right arrangements). There is no global framework for supporting biotech 
research and development that addresses the common needs of poor people in many countries 
and regions. The CGIAR system could be it! 
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